Qianhai Health Holdings Limited Schedules Board Meeting to Approve 2025 Full-Year Results and Consider Final Dividend

Key Highlights for Investors

• Date of Board Meeting: The Board of Directors of Qianhai Health Holdings Limited (Stock Code: 911) will convene a meeting on Wednesday, 18 March 2026.
• Purpose of Meeting: The main agenda includes:
  • Reviewing and approving the audited financial results of the Company and its subsidiaries for the fiscal year ended 31 December 2025.
  • Considering the publication of audited results for shareholder and public review.
  • Deliberating and possibly recommending the payment of a final dividend for the 2025 financial year.

Potentially Price Sensitive Information

• The Board will discuss the final audited results for the year ended 31 December 2025. The financial performance and any announcements regarding profitability, losses, or exceptional items could significantly impact the share price.
• The consideration and potential recommendation of a final dividend is a critical point for shareholders. A declared dividend or a change in dividend policy often influences investor sentiment and share valuation.

Details for Shareholders

• Investors should note that the publication of the audited results and any dividend announcement will provide key insights into the Company’s financial health and future outlook.
• Shareholders are advised to closely monitor the Company’s official disclosures around the date of the Board meeting, as significant financial information and dividend details will likely be released.

Board Composition

The current Board of Directors comprises:

• Non-executive Directors: Mr. Huang Zhiqun (Chairman), Mr. Chen Kaiben, Mr. Chen Qi
• Executive Directors: Mr. Tang Yu Yuan, Mr. Yuen Chee Lap Carl
• Independent Non-executive Directors: Mr. Li Wei, Mr. Leung Chun Tung, Ms. Wu Hung Yu

Investor Action

The upcoming Board meeting and its outcomes are potentially market-moving events. Investors should stay informed about the official announcements and be prepared for possible volatility in the Company’s share price following the release of the audited results and any dividend declarations.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review all official disclosures and consult their financial advisors before making any investment decisions. The author and publisher accept no liability for any losses arising from the use of this information.

View QIANHAI HEALTH Historical chart here